BNGO BIONANO GENOMICS INC

Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023

Bionano to Report Second Quarter 2023 Financial Results and Host a Conference Call and Webcast on August 9, 2023

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 9, 2023, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2023 and to highlight recent corporate progress.

Conference Call & Webcast Details

Date:Wednesday, August 9th, 2023
Time:4:30 p.m. ET
Participant Call Link:

Webcast Link:

Participants may access a live webcast of the call on the Investors page of the Bionano website. A replay of the conference call and webcast will be archived on Bionano’s investor relations website at  for at least 30 days.

CONTACTS

Company Contact:

Erik Holmlin, CEO

Bionano Genomics, Inc.

+1 (858) 888-7610

 

Investor Relations:

David Holmes

Gilmartin Group

+1 (858) 888-7625

 



EN
02/08/2023

Underlying

BNGOBIONANO GENOMICS INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on BIONANO GENOMICS INC

 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides...

Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 Conference call today, March 23, 2026, at 4:30 PM ET SAN DIEGO, March 23, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2025. "2025 demonstrated the momentum we built as a business,” commented Erik Holmlin, PhD, president and CEO of Bionano. “Our routine users of optical genome mapping (OGM) and VIA™ software remain the foundation of our revenue and gross margins, and we are pleased to s...

March 23, 2026 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano Announces Two-Fold Increase in OGM Studies Presented at the 20...

Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics (NASDAQ: BNGO) participated in the 2026 American College of Medical Genetics and Genomics Annual Meeting (ACMG), held March 14–18 in Baltimore, Maryland. Twelve studies, representing a two-fold increase over the number of studies in 2025, were presented as either oral (4) or poster presentations (8). The studies illustrated how optical genome mapping (OGM) can drive ...

March 17, 2026 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results ...

Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 SAN DIEGO, March 09, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Monday, March 23, 2026, at 4:30 p.m. Eastern Time to report financial results for the fourth quarter and full year 2025 and to highlight recent corporate progress. Conference Call & Webcast Details Date:Monday, March 23rd, 2026Time:4:30 p.m. ETParticipant Link:Webcast Link: Participants may access a live webcast o...

March 9, 2026 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadt...

Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale SAN DIEGO, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from the fourth and final day of Symposium 2026. Day 4 featured updates from some of the most advanced and high-volume cytogenetics and molecular pathology laboratories in the United States, Canada and Europe describing how they envision scaling optical genome mapping (OGM), including processing up to thousands of samples per year with automatio...

February 27, 2026 1 EN
 PRESS RELEASE
Free
BNGO BIONANO GENOMIC...

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Uti...

10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how these conditions, which include developmental delay, intellectual disability, neuromuscular disorders, reproductive disorders, birth defects and other so-called rare diseases, present unique challenges to t...

February 26, 2026 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch